Publication | Closed Access

The peroxisome-proliferator activated receptor-γ agonist pioglitazone modulates aberrant T cell responses in systemic lupus erythematosus

InflammationAutoimmune DiseaseImmune DysregulationSystemic Lupus ErythematosusLupusImmune RegulationImmunologyImmune SurveillanceAutoimmunityT Cell ImmunityImmune FunctionReceptor-γ Agonist PioglitazoneCellular Immune ResponseMedicineCell BiologyRegulatory T Cell Biology